Nanosonics Limited
ASX:NAN.AX
Overview | Financials
Company Name | Nanosonics Limited |
Symbol | NAN.AX |
Currency | AUD |
Price | 3.305 |
Market Cap | 1,002,631,240 |
Dividend Yield | 0% |
52-week-range | 2.59 - 4.76 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Michael C. Kavanagh BSc, M.B.A. |
Website | https://www.nanosonics.com.au |
An error occurred while fetching data.
About Nanosonics Limited
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD